ST

Shruti Tiwari

Active Director Director DIN 07439137
DIN 07439137 First appointment Feb 2016 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2016
Shareholding value •••• Premium profile

About Shruti Tiwari

Data last updated:

Shruti Tiwari is a Director at Esteve Pharma Limited (since 2016). The company operates in Pharma. Esteve Pharma Limited reported revenue of ₹7.63 Cr (FY 2024).

DIN 07439137
Primary Designation Director
Industry Pharma
First Appointment 15 Feb 2016
Oldest Company Age 10 yrs
Largest company Esteve Pharma Limited · ₹7.63 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Esteve Pharma Limited U74900UR2016PLC001918
Director15 Feb 20162016₹7.63 Cr (FY 2024)Active

Board colleagues of Shruti Tiwari

NameDINCompanyDesignation
Himanshu Shekhar07433985Esteve Pharma LimitedDirector
Sarwavash Kumar10661403Esteve Pharma LimitedDirector

Directorship timeline

Open interactive timeline →
Esteve Pharma Limited
Premium access

Shareholding and investment profile for Shruti Tiwari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shruti Tiwari

Shruti Tiwari currently holds 1 directorship: Esteve Pharma Limited (Director, since 15 Feb 2016, revenue ₹7.63 Cr (FY 2024)).

Shruti Tiwari was first appointed on 15 Feb 2016 as Director at Esteve Pharma Limited.

The current boards of Shruti Tiwari's companies include Himanshu Shekhar (Esteve Pharma Limited), Sarwavash Kumar (Esteve Pharma Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available